A Population of HLA-DR+ Immature Cells Accumulates in the Blood Dendritic Cell Compartment of Patients with Different Types of Cancer

This publication has 46 references indexed in Scilit:

• Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
  Immunology & Cell Biology, 2005
• Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli
  Blood, 2003
• Characterization of human blood dendritic cell subsets
  Blood, 2002
• Dendritic Cells in Cancer Immunotherapy
  Annual Review of Immunology, 2000
• Immunobiology of Dendritic Cells
  Annual Review of Immunology, 2000
• In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas
  The Journal of Experimental Medicine, 1999
• CD1A DENDRITIC CELLS PREDOMINATE IN TRANSITIONAL CELL CARCINOMA OF BLADDER AND KIDNEY BUT ARE MINIMALLY ACTIVATED
  Journal of Urology, 1999
• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
  Nature Medicine, 1996
• Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.
  The Journal of Experimental Medicine, 1995
• Inhibition of tumor growth by elimination of granulocytes.
  The Journal of Experimental Medicine, 1995